信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01801 信达生物

未开盘 07-09 16:08:03

86.350

+0.150

+0.17%

最高88.700	最低84.150	成交量1,324万
今开85.300	昨收86.200	日振幅5.28%
总市值1,503亿	流通市值1,503亿	总股本17.41亿
成交额11.49亿	换手率0.76%	流通股本17.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":86.35,"timestamp":1783584483004,"preClose":86.2,"halted":0,"volume":13244177,"delay":0,"changeRate":0.001740139211136792,"floatShares":1741000000,"shares":1741000000,"eps":0.469999,"marketStatus":"未开盘","change":0.15,"latestTime":"07-09 16:08:03","open":85.3,"high":88.7,"low":84.15,"amount":1148785510,"amplitude":0.052784,"askPrice":86.4,"askSize":500,"bidPrice":86.35,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":0.52302,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783647000000},"marketStatusCode":0,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":86.2,"openAndCloseTimeList":[[1783560600000,1783569600000],[1783573200000,1783584000000]],"volumeRatio":0.580897,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.5644,"impliedVolPercentile":0.6857},"requestUrl":"/m/hq/s/01801","defaultTab":"news","newsList":[{"id":"2650948151","title":"中泰国际：维持信达生物(01801.HK)买入评级 目标价134.50港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650948151","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650948151?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:55","pubTimestamp":1783565738,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KURE","LU2097828714.EUR","BK1583","LU2097828474.EUR","LU2488822045.USD","BK1161","LU2242644610.SGD","LU2328871848.SGD","LU0502904849.HKD","LU2097828631.EUR","LU1969619763.USD","01801","LU2097828557.USD","HK0000165453.HKD","BK1589","LU2097828805.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650107469","title":"【券商聚焦】中泰国际重申信达生物(01801)“买入”评级 预计医药产品销售收入将快速增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2650107469","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650107469?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:31","pubTimestamp":1783564299,"startTime":"0","endTime":"0","summary":"由于公司与辉瑞的合作项目为早期管线产品与全新项目，首付款入账时间未定，暂不纳入收入预测。由于公司的核心业务医药产品销售收入将快速增加，随着海外合作项目的研发推进授权费也有望进一步落实，因此公司值得关注，重申“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985467","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","KCE","159938","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649795292","title":"国家科技进步奖二等奖|市一孙晓东团队打破垄断，攻克“一小一老”致盲难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2649795292","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649795292?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:26","pubTimestamp":1783481187,"startTime":"0","endTime":"0","summary":"致盲性眼底病是全球首位不可逆盲病因，遗传性视网膜病变（IRD）和老年性黄斑变性（AMD）作为“一小一老”的首要眼底病，构成我国防盲重点核心人群。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798142985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828557.USD","BK1161","BK1583","LU0502904849.HKD","LU2097828714.EUR","LU2097828474.EUR","01801","LU0455707207.USD","LU1969619763.USD","LU2488822045.USD","KURE","BK1589","LU2328871848.SGD","LU2097828805.USD","HK0000165453.HKD","LU2097828631.EUR","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649821952","title":"上海市一医院研发全球首创药，保住“一老一小”千万双眼睛 | 国家科技奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2649821952","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649821952?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:22","pubTimestamp":1783480960,"startTime":"0","endTime":"0","summary":"致盲性眼底病是全球居首的不可逆致盲病因。在我国，罹患遗传性视网膜病变的患儿，以及罹患老年性黄斑变性的老年人，不仅数量庞大，且分别面临缺少有效治疗方案，或须每月进行眼内注射治疗直至终身的临床难题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798139386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828631.EUR","LU2097828805.USD","BK1589","LU0502904849.HKD","LU2097828557.USD","LU2242644610.SGD","LU2328871848.SGD","BK1161","LU1969619763.USD","BK1583","01801","KURE","LU2097828474.EUR","HK0000165453.HKD","LU2488822045.USD","LU0455707207.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142316073","title":"信达生物发行约188.23万股新股，占已发行股本约0.1083%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142316073","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142316073?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:46","pubTimestamp":1783435608,"startTime":"0","endTime":"0","summary":"2026年7月7日，信达生物(01801)发布翌日披露报表。公告显示，公司根据其于2018年6月12日采纳的首次公开募股后员工持股计划，于2026年7月3日向相关董事及员工授予的购股权进行行使并配发及发行普通股，涉及发行新股约188.23万股，占发行前公司已发行股本的0.1083%，每股发行价为41.5228港元，合计约7,815.98万港元。\n本次增发后，公司于2026年7月3日的已发行股本增至17.40亿股，并维持无库藏股。公司表示，上述股份发行经董事会正式授权批准，并已遵照所有适用的联交所证券上市规则及相关法律法规规定进行。\n本次公告由联席公司秘书王艳菊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"信达生物发行约188.23万股新股，占已发行股本约0.1083%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175872587","title":"信达生物：7月6日发行752,381股，涉资约2,129.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175872587","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175872587?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:46","pubTimestamp":1783435579,"startTime":"0","endTime":"0","summary":"7月7日，信达生物(01801)发布公告称，公司根据其于2018年6月12日采纳的首次公开发售后员工持股计划，已于2026年7月6日配发及发行752,381股普通股。\n上述新增股份约占本次股份发行前公司已发行股本的0.0432%。每股发行价为28.3港元，对应发行总金额约21,292,382.30港元（约合2,129.24万港元）。本次股份发行完成后，公司已发行股本由1,740,168,437股增至1,740,920,818股。\n公告同时显示，相关股份发行已获得董事会正式授权，并符合所有适用法例及香港联合交易所有限公司的上市规则。公告由联席公司秘书王艳菊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"信达生物：7月6日发行752,381股，涉资约2,129.24万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649935006","title":"信达生物(01801)根据股份计划发行188.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649935006","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649935006?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:44","pubTimestamp":1783435446,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信达生物(01801)发布公告，于2026年7月3日根据公司于2018年6月12日采纳的首次公开发售后雇员持股计划所授予的购股权而配发及发行188.2万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0502904849.HKD","LU2242644610.SGD","LU2097828805.USD","LU2097828474.EUR","LU2328871848.SGD","BK1161","01801","LU2097828557.USD","BK1583","HK0000165453.HKD","LU1969619763.USD","KURE","LU2488822045.USD","LU2097828631.EUR","LU0455707207.USD","BK1589","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649350099","title":"信达生物(01801.HK)根据股份计划发行188.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649350099","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649350099?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:44","pubTimestamp":1783435446,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KURE","LU2097828557.USD","LU0502904849.HKD","BK1161","01801","LU2097828631.EUR","BK1589","LU2097828474.EUR","LU2242644610.SGD","BK1583","LU0455707207.USD","LU2328871848.SGD","LU2097828714.EUR","LU1969619763.USD","LU2488822045.USD","HK0000165453.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147684632","title":"信达生物6月股份变动月报：月内新增发行38,870股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147684632","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147684632?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:41","pubTimestamp":1783435284,"startTime":"0","endTime":"0","summary":"信达生物制药于2026年7月7日公告了2026年6月的股份变动月报。报告期为2026年6月1日至2026年6月30日，整体股本结构及变动情况如下：。信达生物制药法定注册股本维持5,000,000,000股普通股，面值为每股USD 0.00001，总额USD 50,000，与上期结存一致。根据公告，信达生物制药当月通过多项激励计划增发股份38,870股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106535426","title":"异动解读｜信达生物盘中下跌3.04%，报87.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106535426","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106535426?lang=zh_cn&edition=full","pubTime":"2026-07-07 13:35","pubTimestamp":1783402556,"startTime":"0","endTime":"0","summary":"7月7日，信达生物盘中下跌3.04%，报87.75港元/股，成交额6.88亿港元。信达生物所在的生物科技行业中，板块整体承压，个股中，荣昌生物跌5.35%，康方生物跌3.24%，百济神州跌2.05%，科伦博泰生物跌1.72%，康诺亚-B跌1.21%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161259814","title":"异动解读｜信达生物盘中上涨3.19%，礼来合作与玛仕度肽医保初审利好持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1161259814","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161259814?lang=zh_cn&edition=full","pubTime":"2026-07-06 09:42","pubTimestamp":1783302130,"startTime":"0","endTime":"0","summary":"7月6日，信达生物盘中上涨3.19%，报91.65港元/股，成交额4.07亿港元，延续近期强势表现。此外，7月1日信达生物华南仓正式启用，进一步强化供应链能力。板块层面，生物科技股持续走强，荣昌生物涨5.35%、三生制药涨4.65%、康方生物涨3.71%，行业共振对股价形成支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183416333","title":"异动解读｜信达生物盘中上涨3.57%，礼来合作与玛仕度肽医保初审利好延续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1183416333","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183416333?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:38","pubTimestamp":1783042698,"startTime":"0","endTime":"0","summary":"7月3日，信达生物盘中上涨3.57%，报87.25港元/股，成交额2.57亿港元，延续近日强势表现。消息面上，公司近期利好密集：6月30日与礼来就CDK4/6抑制剂唯择®（阿贝西利片）签署中国大陆商业化协议，信达全权负责该药物的进口、销售及推广，补齐乳腺癌管线商业版图；此外，核心产品玛仕度肽于6月29日通过国家医保药品目录初审，向纳入医保报销迈出关键一步。板块层面，生物科技股持续走强，三生制药涨4.69%、荣昌生物涨4.25%、科伦博泰生物涨3.94%，行业共振对股价形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648634520","title":"【券商聚焦】中信建投：看好相关创新药及制药企业医保准入与商保增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2648634520","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648634520?lang=zh_cn&edition=full","pubTime":"2026-07-03 08:36","pubTimestamp":1783038993,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究指，2026年6月29日，国家医保局公示通过2026年基本医保目录及商保创新药目录调整初步形式审查的药品名单及相关信息。叠加今年首次引入的“预申报”机制，本次结果充分体现了医保目录调整对创新药的持续倾斜，看好相关创新药及制药企业的医保准入与商保增量空间。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985028","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0856984785.SGD","LU1688375341.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU0315179316.USD","LU0516422366.SGD","BK1589","LU2778985437.USD","159992","LU2097828631.EUR","09926","LU2039709279.SGD","06185","06978","09688","601066","LU1242518931.SGD","01477","LU2488822045.USD","LU2097828805.USD","LU2097828714.EUR","01093","LU0043850808.USD","LU0417516902.SGD","LU0979878070.USD","LU0456846285.SGD","IE00B031HY20.USD","HK0000165453.HKD","SG9999004220.SGD","LU0417516738.SGD","01177","06160","LU0067412154.USD","LU1226287875.USD","01877","02616","LU3063872942.SGD","02142","LU1226287792.SGD","LU2476274720.SGD","LU0348766576.USD","LU1961090484.USD","LU1969619763.USD","LU0501845795.SGD","LU2476274308.USD","01801","LU0072913022.USD","09995","02269","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648769005","title":"港股异动 | 信达生物(01801.HK)午前涨超7% 近日与礼来就唯择®在中国内地权益达成商业化合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2648769005","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648769005?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:58","pubTimestamp":1782964707,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","LU2097828714.EUR","LU1969619763.USD","LU0502904849.HKD","LU2097828631.EUR","HK0000165453.HKD","LU2242644610.SGD","LU2328871848.SGD","BK1583","BK1589","LU2097828474.EUR","LU2097828805.USD","LU2488822045.USD","LU0455707207.USD","LU2097828557.USD","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648575107","title":"港股直击 | 创新药概念股继续走高，创新药支付改革加速，药企有望持续步入业绩收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2648575107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648575107?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:36","pubTimestamp":1782963369,"startTime":"0","endTime":"0","summary":"7月2日，创新药概念股继续走高，先声药业、三生制药涨超8%；信达生物涨超7%；康方生物涨近7%。消息面上，国家医保局公布2026年医保目录初审结果，共有557个药品通过医保目录初审，54个药品通过商保创新药目录初审，意味着“医保+商保”双目录谈判进入实质推进阶段。与此同时，预申报机制、8年价格保护等新机制同步落地，进一步完善创新药支付体系，为创新药商业化提供更加稳定的政策预期。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462173.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","LU0417516902.SGD","LU2097828714.EUR","LU1794554557.SGD","LU0540923850.HKD","LU1961090484.USD","LU2097828631.EUR","HK0000165453.HKD","LU2476274720.SGD","LU2488822045.USD","LU0417516738.SGD","IE00BPRC5H50.USD","BK1589","01801","LU2399975544.HKD","IE00B543WZ88.USD","LU0348767384.USD","LU0348735423.USD","BK1593","LU0348783233.USD","LU2476274308.USD","LU0455707207.USD","01530","LU2328871848.SGD","LU0348827113.USD","02096","LU0561508036.HKD","LU1969619763.USD","BK1191","159992","BK4585","BK4588","LU0348784397.USD","BK1161","VXUS","IE00B5MMRT66.SGD","LU2097828805.USD","BK1574","LU0348825331.USD","LU0502904849.HKD","LU2097828557.USD","BK1583","09926","LU1720050803.USD","LU2242644610.SGD","LU0417516571.SGD","LU2778985437.USD","LU0348766576.USD","LU0634319403.HKD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160295781","title":"港股直击 | 恒指涨幅扩大至1.30%，美团升逾6%，快手升逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160295781","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160295781?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:37","pubTimestamp":1782956264,"startTime":"0","endTime":"0","summary":"7月2日，恒生指数涨幅扩大，最新报23171.68点，涨1.27%，成交额474.74亿港元。成分股中，石药集团升9.90%，比亚迪股份升7.04%，中国人寿升6.83%；科网股方面，美团-W升6.20%，快手-W升5.19%，京东集团-SW升5.19%。","market":"hk","thumbnail":"https://static.tigerbbs.com/f1244793084c6388467f46fc7c39784b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f1244793084c6388467f46fc7c39784b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","06618","01801","03692","01177","01024","02628","03690","09618","01093","01211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138822618","title":"异动解读｜信达生物盘中上涨4.27%，礼来商业化合作落地叠加玛仕度肽医保初审通过","url":"https://stock-news.laohu8.com/highlight/detail?id=1138822618","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138822618?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:31","pubTimestamp":1782955873,"startTime":"0","endTime":"0","summary":"7月2日，信达生物盘中上涨4.27%，报83.7港元/股，成交额1.31亿港元。消息面上，公司近日利好密集：6月30日与礼来就CDK4/6抑制剂唯择（阿贝西利片）签署中国大陆商业化协议，信达全权负责国内进口、销售及推广，补齐乳腺癌管线；此外，核心产品玛仕度肽于6月29日通过国家医保药品目录初审，向纳入医保报销迈出关键一步。板块层面，生物科技股今日普涨，三生制药涨9.12%、康诺亚-B涨8.27%、康方生物涨6.3%，板块共振亦对股价形成提振。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578521","title":"港股开盘向好 恒指高开0.83% 京东物流(02618)涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578521","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648578521?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:25","pubTimestamp":1782955544,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘向好，恒指高开0.83%，国企指数高开0.73%，恒生科技指数高开1.25%。京东物流涨5.96%，石药集团涨5.60%，百度集团-SW涨4.93%，比亚迪股份涨4.90%，信达生物涨4.65%。港股在假期前表现反复，指数周二低开后反复向下，收市下跌0.6%，再度失守23,000点水平。预料指数短期将维持于22,500至23,500点之间上落。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984920","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0269904917.USD","LU0417516902.SGD","LU0505663152.USD","LU0164880469.USD","LU1951186391.HKD","LU1226288253.USD","09115","BK1563","SG9999015986.USD","LU0543330566.HKD","BK1502","02833","LU0791590937.USD","LU0165289439.USD","LU0531971595.HKD","LU2097828557.USD","LU2360107325.USD","LU2506951792.HKD","LU0228367735.SGD","BK1614","HYDD.SI","LU0348735423.USD","LU1023057109.AUD","LU2097828805.USD","80883","LU1808992512.USD","LU0823039010.USD","03993","SG9999015945.SGD","LNVGY","00981","LU0359201612.USD","LU2097828714.EUR","SG9999015952.SGD","LU0708995583.HKD","00992","LU0052756011.USD","LU0314109678.HKD","LU2778985437.USD","BIDU","09633","LU0289960550.SGD","BK1594","LU1880383440.USD","IE0008368742.USD","LU0821914370.USD","IE0034224299.USD","LU0320764243.SGD","LU0173614495.USD","LU0143863784.USD","LU1242518857.USD","BK1161","LU0320764755.SGD","LU0327786744.USD","LU0516422952.EUR","LU0072913022.USD","LU0823426480.USD","09888","IE0032431581.USD","IE00B543WZ88.USD","BK1540","LU0708995153.HKD","LU2249611893.SGD","BK1587","BK1582","LU2348774022.SGD","LU0871576103.HKD","LU0823038988.USD","LU1770034418.SGD","01211","LU0531970944.HKD","LU0588545490.SGD","LU2294711713.HKD","SG9999001069.SGD","LU0043850808.USD","LU0823414478.USD","LU2242644610.SGD","LU2351347302.SGD","LU0264606111.USD","03419","BK1575","LU0762541174.USD","LU0449509016.USD","LU0762542818.HKD","SG9999002828.SGD","LU0348825331.USD","IE00BZ08YR35.GBP","603993","LU0244354667.USD","LU0516422440.USD","LU0084288322.USD","LU0326950275.SGD","07300","LU0315178854.USD","BK1521","HK0000320223.HKD","LU1807302812.USD","LU0175139822.USD","LU2476274308.USD","MCHmain","LU1861219969.SGD","LU0289739343.SGD","HHImain","LU0315179316.USD","03037","LU0572944931.SGD","688981","LU1048596156.SGD","SG9999004220.SGD","LU0516423091.SGD","89888","IE00B031HY20.USD","LU0307460666.USD","LU0823414551.USD","LU2148510915.USD","LU0819123356.HKD","LU0128525689.USD","LU0828238088.HKD","LU1064130708.USD","HSTECH","LU0128522744.USD","BK1604","LU0140636845.USD","LU0049112450.USD","BK1522","LU1794554557.SGD","LU1046422090.SGD","LU0543330483.HKD","BK1541","LU1720050803.USD","BK1528","BK1615","LU0511384066.AUD","LU0417516738.SGD","LU0880133367.SGD","LU1064131003.USD","LU2476274720.SGD","LU1880383366.USD","LU1481107354.HKD","LU2328871848.SGD","LU0502904849.HKD","LU0455707207.USD","BK1193","LU2039709279.SGD","LU1267930227.SGD","LU0214875030.USD","LU0588545730.USD","LU0831093199.SGD","LU1115378108.SGD","BK1190","LU1868838027.USD","LU0588546209.SGD","03115","LU1152091754.HKD","LU1366334651.USD","00883","LU1008478684.HKD","LU0320764599.SGD","SG9999004311.SGD","03696","LU0359201885.HKD","07500","LU0630378692.HKD","LU0561508036.HKD","03323","LU2488822045.USD","LU2357125470.USD","HK0000320264.USD","BK1503","BK1583","LU0588545904.SGD","LU1961090484.USD","LU0289961442.SGD","LU0516422366.SGD","LU1226287792.SGD","LU0650527681.SGD","BK1200","LU0594300179.USD","SG9999006597.SGD","BK1609","BK1515","LU0359202008.SGD","SG9999001226.SGD","LU0128522157.USD","LU0540923850.HKD","LU1960683339.HKD","02618","LU0039217434.USD","LU0310800965.SGD","LU1861214812.USD","LU0630378429.USD","LU1242518931.SGD","BK1610","LU2187417386.USD","BK1509","LU1993786604.SGD","LU1226288170.HKD","LU0029875118.USD","LU0865486749.SGD","HK0000165453.HKD","01801","BK1119","LU0819121731.USD","LU0634319403.HKD","IE00BD6J9T35.USD","LU1328277881.USD","LU0605514214.HKD","LU0509642566.USD","LU1328615791.USD","BK1526","LU0348827113.USD","600938","002594","BK1588","SG9999001093.SGD","LU0463099449.HKD","BK1095","LU1226287875.USD","BK1238","LU0287142896.SGD","LU0211977185.USD","BK1191","LU0229945570.USD","IE00BZ08YT58.USD","LU0254981946.USD","SG9999015978.USD","LU0469268626.HKD","LU0052750758.USD","LU0791591158.USD","LU0449515922.USD","LU1366334578.USD","LU2929501877.USD","81211","LU1048588211.SGD","83115","BK1539","LU1235295612.USD","BK1141","LU0856984785.SGD","80992","LU0143863198.USD","LU0572939691.SGD","LU0572940350.SGD","LU0197773673.USD","BK1607","SG9999002463.SGD","LU1969619763.USD","LU0593848301.USD","LU0163747925.USD","BK1163","IE00B5MMRT66.SGD","LU0072462343.USD","LU0501845795.SGD","LU0164865239.USD","LU1251922891.USD","IE00B0JY6N72.USD","LU2097828631.EUR","HSI","IE00B3M56506.USD","LU0149721374.USD","SG9999006514.SGD","LU0823426308.USD","LU0456827905.SGD","82800","HK0000306685.HKD","LU0054450605.USD","07200","LU0862451753.SGD","LU0029874905.USD","LU0067412154.USD","LU0164872284.USD","LU0890818403.SGD","LU0640798160.USD","LU0197773160.USD","LU0051755006.USD","BYDDY","LU0594300419.USD","LU0348805143.USD","513600","BK1589","LU1831875114.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1868837722.USD","LU2213484517.USD","LU2449936058.SGD","LU2399975544.HKD","LU1152091168.USD","LU1981816686.USD","LU0762540952.USD","LU2153592121.USD","LU1188198961.HKD","LU1303224171.USD","LU1719994722.HKD","LU2097828474.EUR","LU0672654166.SGD","BK1592","LU0862451837.USD","LU1226287529.USD","CBUMY","02800","LU1813983027.USD","LU1868837565.USD","BK1135","HK0000306701.USD","01093","SG9999014674.SGD","LU0979878070.USD","LU0516423174.USD","NNFSF","BK1151","LU0259732245.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647535758","title":"信达生物与礼来(LLY)签约 独家承接抗癌药国内推广分销业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2647535758","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647535758?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:17","pubTimestamp":1782807459,"startTime":"0","endTime":"0","summary":"金吾财讯 | 信达生物、礼来 (LLY) 联合发布合作公告，双方就 CDK4/6 抑制剂 Verzenios® 阿贝西利签署中国大陆经销推广协议。根据约定，信达生物全权负责该药物在国内的进口、市场宣传、渠道分销与落地推广工作，持有产品独家商业化权益。礼来作为药品上市许可持有人，持续承担药品全周期生产、供货及后续研发迭代工作。本次合作划分生产端与商业化端权责，依托信达生物国内医药渠道资源扩大药物临床覆盖范围，礼来则持续把控药品生产标准与新药研发管线。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302032","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU2097828557.USD","LU2552382132.HKD","SG9999018857.SGD","LU2063271972.USD","LU2097828805.USD","LU2242644610.SGD","LU2112291526.USD","LU2028103732.USD","LU2023251221.USD","LU2361045086.USD","LU0061475181.USD","LU0238689110.USD","LU0353189763.USD","LU1093756168.USD","LU0006306889.USD","LU2168564495.EUR","LU2756315664.SGD","BK4007","LU0823416689.USD","LU2097828474.EUR","LU2491050154.USD","IE00B7KXQ091.USD","SG9999014906.USD","LU1064131342.USD","BK4588","LU1868837136.USD","LU0158827948.USD","LU0114720955.EUR","LU1969619763.USD","LLII","LU1548497426.USD","BK1161","LU2361044865.SGD","SG9999013999.USD","LU1069344957.HKD","LU2168564065.EUR","LU2089284900.SGD","LU0133085943.USD","IE00BFSS7M15.SGD","LU0471298777.SGD","LU1127390331.HKD","LU0882574139.USD","BK1583","LU0417517546.SGD","LU2746668461.USD","SG9999015986.USD","LU2237443465.HKD","LU2456880835.USD","LU1868836914.USD","LU1974910355.USD","SG9999018865.SGD","LU0689472784.USD","IE0004445015.USD","LU2552382215.SGD","BK4533","IE00BJJMRX11.SGD","BK1589","LU0109394709.USD","LU2896262040.SGD","LU1868836757.USD","BK4585","LU0456855351.SGD","LU0096364046.USD","LU2264538146.SGD","LU2265009873.SGD","LU2108987350.USD","LU2417539215.USD","LU0158827781.USD","LU0455707207.USD","LU1035775433.USD","BK4581","SGXZ81514606.USD","IE0009355771.USD","IE0001KFT4U8.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1720051017.SGD","BK4599","LU0289739699.SGD","LLYX","LU1057294990.SGD","LU2468319806.SGD","LU0823434740.USD","LU0640476718.USD","LU0316494557.USD","SG9999015978.USD","LU1323610961.USD","LU2357305700.SGD","LU0225283273.USD","LU0094547139.USD","LU0964807845.USD","LU0203202063.USD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU2328871848.SGD","LU1988902786.USD","LU2237443895.HKD","LU2089984988.USD","LU2237438978.USD","LU0882574055.USD","LU2087625088.SGD","LU2462157665.USD","IE00BFSS8Q28.SGD","HK0000165453.HKD","LU2488822045.USD","LU2237443622.USD","01801","LU0320765059.SGD","LLY","LU2111349929.HKD","LU2471134879.HKD","LU2756315318.SGD","LU0354030511.USD","LU2746668974.SGD","IE00B775H168.HKD","LU0502904849.HKD","LU0106261372.USD","LU0820561818.USD","IE00BJLML261.HKD","SG9999001176.USD","LU1267930730.SGD","IE0002141913.USD","SG9999014914.USD","IE00BFTCPJ56.SGD","LU2491049909.HKD","LU0203201768.USD","LU2361044949.HKD","LU2237443382.USD","LU2023250330.USD","LU2750360641.GBP","GB00BDT5M118.USD","LU0708995401.HKD","LU1629891620.HKD","IE00BK4W5L77.USD","LU0058720904.USD","IE00BK4W5M84.HKD","LU0354030438.USD","LU0385154629.USD","LU2097828631.EUR","LU1061106388.HKD","SG9999001176.SGD","SG9999014898.SGD","SGXZ31699556.SGD","LU0097036916.USD","LU2023250504.SGD","LU0683600562.USD","IE00BKDWB100.SGD","LU1983299246.USD","LU2168563687.JPY","LU0353189680.USD","LU0823434583.USD","LU1804176565.USD","LU2236285917.USD","LU2324357040.USD","LU1551013342.USD","LU0466842654.USD","LU1145028129.USD","IE00B2B36J28.USD","LU0256863811.USD","SG9999014880.SGD","LU0109391861.USD","LU0122379950.USD","LU0787776722.HKD","LU2097828714.EUR","IE00B4JS1V06.HKD","LU0672654240.SGD","LU1720051108.HKD","LU1868837300.USD","LLYZ","LU2491050071.SGD","LU2237443978.SGD","LU1232071149.USD","IE0004445239.USD","LU2211815571.USD","LU0198837287.USD","LU2471134523.USD","LU0943347566.SGD","LU2471134796.USD","LU2213496289.HKD","SG9999015952.SGD","LU2471134952.CNY","LU0820561909.HKD","BK4516","LU0266013472.USD","LU2237443549.SGD","SGXZ57979304.SGD","LU1093756325.SGD","LU2089283258.USD","SG9999017495.SGD","BK4534","LU2106854487.HKD","IE00BKPKM429.USD","LU0889565916.HKD","LU1280957306.USD","LU1291159041.SGD","IE00B1XK9C88.USD","LU1712237335.SGD","LU0210536198.USD","ELIS","IE00B1BXHZ80.USD","LU0079474960.USD","LU0323591593.USD","LU1551013425.SGD","LU2750360997.AUD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU0820562030.AUD","LU2168564222.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2271345857.HKD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU1623119135.USD","LU2360106947.USD","SG9999015945.SGD","LU0786609619.USD","LU2168564149.EUR","ELIL","IE00BN29S564.USD","LU1023059063.AUD","LU1989771016.USD","LU0256863902.USD","LU1366192091.USD","LU0432979614.USD","LU2602419157.SGD","LU1814569148.SGD","IE00BJJMRY28.SGD","LU2552382058.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647848525","title":"信达生物与礼来签订唯择中国商业化合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2647848525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647848525?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:15","pubTimestamp":1782792951,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0001KFT4U8.USD","LU1291159041.SGD","IE00B1XK9C88.USD","LU1868836757.USD","LU0122379950.USD","LU2471134952.CNY","IE00BJJMRY28.SGD","LLII","LU1983299246.USD","LU2237443465.HKD","LU0266013472.USD","LLYX","LU0058720904.USD","LU0354030511.USD","BK4534","LU2491050071.SGD","LU0353189763.USD","LU2089984988.USD","LU0471298694.HKD","LU2462157665.USD","LU0455707207.USD","LU2063271972.USD","LU2357305700.SGD","LU0094547139.USD","BK1589","LU2097828714.EUR","LU2097828805.USD","LU2237443549.SGD","LU2237443382.USD","SG9999018857.SGD","LU1093756168.USD","LU2108987350.USD","LU2746668974.SGD","LU0708995401.HKD","LU2111349929.HKD","LU2264538146.SGD","SGXZ51526630.SGD","01801","LU0683600562.USD","SG9999014906.USD","LU0256863811.USD","LU0006306889.USD","LU2168564495.EUR","LU2461242641.AUD","LU0323591593.USD","LU0823416689.USD","LU0823434740.USD","BK1583","BK4581","SGXZ31699556.SGD","LU2168564149.EUR","LU1551013342.USD","LU1093756325.SGD","LU1804176565.USD","LU2242644610.SGD","IE00BJJMRX11.SGD","LU0289739699.SGD","LU1323610961.USD","SG9999017495.SGD","SGXZ81514606.USD","LU2168563687.JPY","LU1023059063.AUD","LU1629891620.HKD","LU0061475181.USD","SGXZ99366536.SGD","LU2213496289.HKD","LU2491050154.USD","SG9999014914.USD","IE00BKDWB100.SGD","IE00B1BXHZ80.USD","LU1720051017.SGD","LU1868836591.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","IE0004445015.USD","GB00BDT5M118.USD","LU1720051108.HKD","LU0471298777.SGD","LU0823434583.USD","LU0889565916.HKD","IE00BN29S564.USD","LU0964807845.USD","SG9999014880.SGD","LU1551013425.SGD","BK4007","IE0004445239.USD","IE00B4JS1V06.HKD","LU2168564065.EUR","LU0787776722.HKD","LU0256863902.USD","IE00BJT1NW94.SGD","LU1280957306.USD","BK4585","LU1035775433.USD","LU2602419157.SGD","LU0203201768.USD","SG9999015978.USD","LU0502904849.HKD","LU2746668461.USD","LU0203202063.USD","LU0225283273.USD","LLY","LU2097828631.EUR","IE00BFTCPJ56.SGD","LU1969619763.USD","LU1989771016.USD","LU0943347566.SGD","LU2097828474.EUR","LU0234572021.USD","LU2237438978.USD","LU2417539215.USD","SG9999001176.USD","LU2211815571.USD","IE00B7KXQ091.USD","SG9999015952.SGD","LU0109394709.USD","LU2236285917.USD","LU0158827781.USD","LU2750360997.AUD","LU0210536198.USD","LU2468319806.SGD","LU0320765992.SGD","LU2552382058.USD","LU2361044949.HKD","LU2087625088.SGD","LU0786609619.USD","IE00BKPKM429.USD","LU1623119135.USD","LU2112291526.USD","LU2023250330.USD","SG9999014898.SGD","SG9999013999.USD","LU1988902786.USD","LU1127390331.HKD","LU2271345857.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2168564222.USD","LU1366192091.USD","LU0354030438.USD","IE0005OL40V9.USD","LU0417517546.SGD","LU1917777945.USD","LU0432979614.USD","LU2491049909.HKD","LU2750360641.GBP","LLYZ","LU1057294990.SGD","IE0002141913.USD","SG9999015986.USD","LU1069344957.HKD","LU0320765059.SGD","BK4516","LU0198837287.USD","LU2089283258.USD","LU2028103732.USD","BK4533","LU0316494557.USD","LU2471134879.HKD","LU0079474960.USD","LU1267930730.SGD","LU1061106388.HKD","LU1974910355.USD","SG9999015945.SGD","LU0820561909.HKD","LU2896262040.SGD","LU0096364046.USD","IE00B775H168.HKD","HK0000165453.HKD","SG9999001176.SGD","IE00BWXC8680.SGD","IE00B4R5TH58.HKD","LU2328871848.SGD","LU0466842654.USD","LU0114720955.EUR","LU0456855351.SGD","LU1814569148.SGD","LU2756315318.SGD","LU2552382215.SGD","LU2471134523.USD","LU2471134796.USD","LU0689472784.USD","IE00BJLML261.HKD","LU1548497426.USD","LU2023250504.SGD","LU0820562030.AUD","BK1161","IE00BK4W5L77.USD","LU2023251221.USD","ELIL","LU0385154629.USD","LU0097036916.USD","LU1064131342.USD","BK4599","LU1145028129.USD","IE0009355771.USD","IE00BFSS7M15.SGD","LU0353189680.USD","IE00B2B36J28.USD","SG9999018865.SGD","LU2488822045.USD","LU0820561818.USD","LU2237443978.SGD","ELIS","LU2361044865.SGD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU0882574139.USD","LU0158827948.USD","LU0238689110.USD","LU2237443622.USD","LU1868837300.USD","LU0106261372.USD","LU0672654240.SGD","SGXZ57979304.SGD","LU0640476718.USD","LU1232071149.USD","LU1868836914.USD","BK4588","LU2456880835.USD","LU2097828557.USD","LU0109391861.USD","LU0882574055.USD","LU2324357040.USD","LU0133085943.USD","LU2265009873.SGD","LU1712237335.SGD","LU2089284900.SGD","LU2361045086.USD","LU1868837136.USD","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.1805},{"period":"3month","weight":-0.0243},{"period":"6month","weight":-0.033},{"period":"1year","weight":0.0498},{"period":"ytd","weight":0.1325}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0218},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.0839},{"period":"1year","weight":0.0058},{"period":"ytd","weight":-0.0624}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041076},{"month":2,"riseRate":0.75,"avgChangeRate":0.110526},{"month":3,"riseRate":0.25,"avgChangeRate":-0.01934},{"month":4,"riseRate":0.75,"avgChangeRate":0.043223},{"month":5,"riseRate":0.375,"avgChangeRate":0.014737},{"month":6,"riseRate":0.625,"avgChangeRate":0.116146},{"month":7,"riseRate":0.5,"avgChangeRate":0.019399},{"month":8,"riseRate":0.714286,"avgChangeRate":0.000214},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.02286},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"信达生物","nameEN":"INNOVENT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信达生物,01801,信达生物股票,信达生物股票老虎,信达生物股票老虎国际,信达生物行情,信达生物股票行情,信达生物股价,信达生物股市,信达生物股票价格,信达生物股票交易,信达生物股票购买,信达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}